There has been a new development in vaccine studies for the HIV virus, which has no definitive treatment yet and causes deaths from AIDS (Acquired Immune Deficiency Syndrome) in advanced stages. The vaccine developed by a group of experts from the National Institute of Biomedical Innovation, Health and Nutrition in Japan has announced that it has succeeded in inactivating the HIV virus in monkeys.
IT WILL BE TRIED ON PEOPLE IN 5 YEARS
Injecting HIV virus into 7 macaque monkeys within the scope of the study, the team determined that the 4 monkeys tested were infected with the virus, but the virus became undetectable after a short time. Noting that the immune system stimulated by the vaccine makes HIV lose its effect, experts announced that trials on humans will begin in about 5 years. The vaccine, which is stated to play an important role in the effective treatment of AIDS if successful, is expected to encourage new drug and vaccine development studies.
40 MILLION PEOPLE CARRY VIRUS WORLDWIDE
HIV, which can settle in various tissues of the body and show its main effects on the immune system, causes AIDS in the later stages, leaving the immune system vulnerable to diseases. According to the data of the World Health Organization (WHO), 37.7 million people worldwide carry the deadly HIV virus as of 2020.
Source: UAV